Discussion:
Drugmaker UCB backs Brexit Britain with 1 billion pound investment
Add Reply
Bod
2018-12-05 06:06:13 UTC
Reply
Permalink
Britain came out on top as the most suitable site, thanks to its strong
science culture. The decision will support 650 jobs and means the UK
will remain home to one of UCB’s two global discovery research centres,
with the other being in Belgium.

A year ago the British government trumpeted similar investment
commitments by MSD, known as Merck & Co (MRK.N) in the United States,
and German-based diagnostics company Qiagen (QIA.DE).

The highly regulated drugs sector is one of the most vulnerable to
Britain’s decision to leave the EU because of uncertainty over how
medicines oversight will function in the event of an abrupt exit.

But pharmaceutical companies are still attracted by the country’s
world-class talent in biological science and its reputation as a
significant centre of drug development.

https://uk.reuters.com/article/uk-britain-eu-pharmaceuticals/drugmaker-ucb-backs-brexit-britain-with-1-billion-pound-investment-idUKKBN1O4007
--
Bod
R. Mark Clayton
2018-12-05 11:50:39 UTC
Reply
Permalink
Post by Bod
Britain came out on top as the most suitable site, thanks to its strong
science culture. The decision will support 650 jobs and means the UK
will remain home to one of UCB’s two global discovery research centres,
with the other being in Belgium.
A year ago the British government trumpeted similar investment
commitments by MSD, known as Merck & Co (MRK.N) in the United States,
and German-based diagnostics company Qiagen (QIA.DE).
The highly regulated drugs sector is one of the most vulnerable to
Britain’s decision to leave the EU because of uncertainty over how
medicines oversight will function in the event of an abrupt exit.
But pharmaceutical companies are still attracted by the country’s
world-class talent in biological science and its reputation as a
significant centre of drug development.
https://uk.reuters.com/article/uk-britain-eu-pharmaceuticals/drugmaker-ucb-backs-brexit-britain-with-1-billion-pound-investment-idUKKBN1O4007
--
Bod
The reality is that the tide has now turned.
Bod
2018-12-05 11:57:39 UTC
Reply
Permalink
Post by R. Mark Clayton
Post by Bod
Britain came out on top as the most suitable site, thanks to its strong
science culture. The decision will support 650 jobs and means the UK
will remain home to one of UCB’s two global discovery research centres,
with the other being in Belgium.
A year ago the British government trumpeted similar investment
commitments by MSD, known as Merck & Co (MRK.N) in the United States,
and German-based diagnostics company Qiagen (QIA.DE).
The highly regulated drugs sector is one of the most vulnerable to
Britain’s decision to leave the EU because of uncertainty over how
medicines oversight will function in the event of an abrupt exit.
But pharmaceutical companies are still attracted by the country’s
world-class talent in biological science and its reputation as a
significant centre of drug development.
https://uk.reuters.com/article/uk-britain-eu-pharmaceuticals/drugmaker-ucb-backs-brexit-britain-with-1-billion-pound-investment-idUKKBN1O4007
--
Bod
The reality is that the tide has now turned.
Your are a simply a pessimist.
Most Brexit predictions have been way out.

Chief economist of Bank of England admits errors in Brexit forecasting ...
https://www.theguardian.com/.../chief-economist-of-bank-of-england-admits-errors
5 Jan 2017 - Why has the UK economy defied predictions of doom? ...
attacked the Bank of England governor, Mark Carney, for predicting ...
Flanders, who now works for JP Morgan, agreed that economists had a long
record of being wrong on direct ... for an age when consumers and
businesses, and especially banks, ...
--
Bod
Loading...